Aluminum adjuvant-adsorbed vaccine antigen

Aluminum adjuvant-adsorbed vaccine antigens represent a critical formulation state in vaccinology where protein antigens are physically bound to the surface of aluminum salts, such as aluminum hydroxide or aluminum phosphate. This surface binding occurs through mechanisms including electrostatic attraction, hydrophobic interactions, and ligand exchange, which effectively transforms soluble proteins into particulate forms that are more readily internalized by antigen-presenting cells (APCs) [1, 2]. Biologically, these complexes act as a depot at the injection site, providing a sustained release of the antigen and prolonged stimulation of the immune system [5]. Furthermore, the particulate nature of the complex triggers the recruitment of neutrophils and monocytes and activates the NLRP3 inflammasome within macrophages, leading to the secretion of pro-inflammatory cytokines like IL-1β [3, 4]. This process primarily drives a Th2-polarized immune response, which is highly effective for generating high titers of neutralizing antibodies against bacterial toxins and viral surface proteins [1]. Despite their widespread use, these complexes are generally ineffective at stimulating the Th1 or cytotoxic T-lymphocyte responses required for clearing intracellular pathogens or treating cancers [4]. References: [1] Marrack P, et al. (2009) Nat Rev Immunol 9(4):287-93; [2] HogenEsch H. (2002) Vaccine 20 Suppl 3:S34-9; [3] Kool M, et al. (2008) J Exp Med 205(4):869-82; [4] Exley C, et al. (2010) Trends Immunol 31(3):103-9; [5] Ghimire TR. (2015) Vaccine 33(41):5313-21.

Other names

Alum-adsorbed antigenAluminum-adsorbed vaccine proteinAlum-precipitated antigenAluminum hydroxide-antigen complexAluminum phosphate-antigen complex

The complex functions by adsorbing protein antigens onto the surface of aluminum salts, creating a depot for slow antigen release, enhancing phagocytosis by dendritic cells, and activating the NLRP3 inflammasome to induce a Th2-biased immune response.